AP
DXCM icon

Arlington Partners’s DexCom DXCM Stock Holding History

Arlington Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61
Closed -$7.84K – 466
2023
Q2 		$7.84K Hold
61
– – ﹤0.01% 479
2023
Q1 		$7.09K Buy
+61
New +$6.83K ﹤0.01% 442
2022
Q1 		– Sell
-176
Closed -$24K – 508
2021
Q4 		$24K Buy
+176
New +$25.3K 0.01% 350

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arlington Partners's DXCM Position: Q3 2023 in Review

Arlington Partners sold out of DexCom (DXCM) in Q3 2023, closing a stake of 61 shares — an estimated $7.84K sold.

Arlington Partners first reported a position in DXCM in Q4 2021 and held it in 3 quarters. The position peaked at $24K in Q4 2021. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Arlington Partners reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Arlington Partners sold 61 DexCom shares in Q3 2023, an estimated $7.84K.
  • Arlington Partners first reported a position in DexCom in Q4 2021 and held it in 3 quarters.
  • Arlington Partners's DexCom position peaked at $24K in Q4 2021.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.